Well AI is pretty smart … I might pick up a few more shares down here .. I do believe with all the data and analysis anavex could preselect trial participants that would practically guarantee a successful trial in that endpoints would be met and efficacy would be demonstrated. I don’t need the shiny new bicycle this Christmas, I can wait , well in theory I can wait until I die so I best make health and happiness top priorities 😁😁
This post hasn't aged well. Check the 2 FDA shifts of policy broadening terms for approval written AFTER the original post.First one, after the negative trend announcement - One trial sufficiency in certain circumstances Second one, after the negative opinion - RWE inclusion